Latest News for: ets-vii

Edit

Protagonist Reports Positive Top Line Results From Phase 2b Study of Icotrokinra Showing Potential to ...

ACCESSWIRE 10 Mar 2025
... signaling in human T cells.vii The license and collaboration agreement established between Protagonist Therapeutics, Inc ... iv Bissonnette R, et al ... v Razawy W, et al ... vi Tang C, et al ... vii Pinter A, et al.
Edit

ViiV Healthcare continues to deliver long-acting injectable HIV innovation with late-breaking data and real-world insights across pipeline and portfolio at CROI 2025

Pharmiweb 10 Mar 2025
[i] Khan T, et al. PILLAR 12 Month Clinical Results ... [ii] Grinsztejn B, et al ... [iii] Sax P, et al ... [iv] Sension M, et al Long-term CAB+RPV LA Effectiveness in Virologically Suppressed Individuals in the OPERA Cohort ... [vii] Tiraboschi JM, et al.
  • 1
×